person · Reporting owner
SCO CAPITAL PARTNERS LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABEONA THERAPEUTICS INC.ABEO · Entity 5808 | Director · 10% owner | May 03, 2021 | May 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABEONA THERAPEUTICS INC.
Report date May 03, 2021 · Filed May 05, 2021
Jointly reported with Rouhandeh Steven H
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSCO Capital Partners LLC | 11,079,292 |
Reported balance
After 2021-05-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-05-03 · Sale · Disposed 80,000 · Balance 11,079,292 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 5, 2021 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.01 | $160,888.00 |
DisclosureSEC source: 0001493152-21-010518 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,079,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.23 | $178,624.00 |
DisclosureSEC source: 0001493152-21-006427 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,159,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.13 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 120,000 | $2.97 | $356,808.00 |
DisclosureSEC source: 0001493152-21-004255 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,239,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.71 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:42 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 240,000 | $3.01 | $722,832.00 |
DisclosureSEC source: 0001493152-21-003285 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,359,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 19, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 207,117 | $2.08 | $431,217.59 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 3 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,599,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 81,283 | $2.02 | $164,085.99 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 2 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,806,409 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 31,600 | $2.00 | $63,212.64 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,887,692 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 1,989 | $2.00 | $3,981.38 |
DisclosureSEC source: 0001493152-20-017963 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,919,292 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 00:35 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 4,600 | $2.01 | $9,243.70 |
DisclosureSEC source: 0001493152-20-017788 · ownership.xml · nonDerivative · entry 2 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,921,281 F2 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F3 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| September 10, 2020 Filed Sep 15, 2020 00:35 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 73,411 | $2.08 | $152,481.99 |
DisclosureSEC source: 0001493152-20-017788 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,925,881 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.01 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F3 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.85 | $228,312.00 |
DisclosureSEC source: 0001493152-20-016305 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,999,292 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.81 to $2.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F2 · price: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.